Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership4,742,611 shares
Ownership 4.40%
Jpmorgan Chase & Co ownership in REGN / Regeneron Pharmaceuticals, Inc.

2025-06-05 - Jpmorgan Chase & Co has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,742,611 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN). This represents 4.4 percent ownership of the company. In their previous filing dated 2025-04-22 , Jpmorgan Chase & Co had reported owning 5,546,434 shares, indicating a decrease of -14.49 percent.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 10,000 of underlying shares valued at $7,492,900 USD and put options representing 15,000 of underlying shares valued at $11,239,350 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-06-05 2025-06-05 13G/A 5,546,434 4,742,611 -14.49 4.40 -13.73
2025-04-22 2025-04-22 13G/A 7,219,436 5,546,434 -23.17 5.10 -23.88
2024-01-25 2024-01-25 13G/A 6,101,044 7,219,436 18.33 6.70 19.64
2024-01-25 2024-01-25 13G/A 6,101,044 7,219,436 18.33 6.70 19.64
2023-01-11 2023-01-11 13G 6,101,044 5.60

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 4,311,806 371,646 9.43 3,230,794 6.23 0.0224
2026-02-11 2025-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 3,940,160 -132,166 -3.25 3,041,293 32.82 0.1909
2025-11-26 2025-09-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 4,072,326 132,708 3.37 2,289,760 10.71 0.1372
2025-11-07 2025-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 4,072,326 132,708 2,289,760 0.0145
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 3,939,618 -1,718,579 -30.37 2,068,312 -42.36 0.1353
2025-05-12 2025-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 5,658,197 -1,401,174 -19.85 3,588,599 -28.64 0.2620
2025-02-12 2024-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 7,059,371 -430,129 -5.74 5,028,603 -36.13 0.3744
2024-12-26 2024-09-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 7,489,500 -787,815 -9.52 7,873,264 -9.50 0.5983
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 7,489,500 -787,815 7,873,264 0.6001
2024-12-26 2024-06-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 8,277,315 550,141 7.12 8,699,707 16.97 0.7133
2024-08-12 2024-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 8,277,315 550,141 8,699,707 0.7147
2024-12-26 2024-03-31 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 7,727,174 500,405 6.92 7,437,328 17.17 0.6283
2024-05-10 2024-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 7,727,174 500,405 7,437,328 0.6291
2024-12-26 2023-12-31 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 7,226,769 -162,385 -2.20 6,347,200 4.38 0.6087
2024-02-12 2023-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 7,226,769 -162,385 6,347,200 0.6098
2023-11-14 2023-09-30 13F Regeneron Pharmaceuticals COM 75886F107 7,389,154 845,167 12.92 6,080,979 29.32 0.6709
2023-08-11 2023-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 6,543,987 199,836 3.15 4,702,117 -9.80 0.5110
2023-05-18 2023-03-31 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 6,344,151 234,606 3.84 5,212,800 118,184.55 0.6350
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 6,293,551 184,006 5,212,800 0.0774
2023-02-13 2022-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 6,109,545 403,676 7.07 4,408 -99.89 0.5811
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 5,705,869 27,437 0.48 3,930,602 17.10 0.5644
2022-08-11 2022-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 5,678,432 713,465 14.37 3,356,691 -3.20 0.4676
2022-05-11 2022-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 4,964,967 373,438 8.13 3,467,632 19.59 0.4176
2022-02-11 2021-12-31 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 4,591,529 489,084 11.92 2,899,642 16.79 0.3349
2022-02-10 2021-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 4,591,529 489,084 2,899,642 0.3319
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 4,102,445 314,052 8.29 2,482,717 17.33 0.3070
2021-08-12 2021-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 3,788,393 752,738 24.80 2,115,969 47.32 0.2524
2021-05-12 2021-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 3,035,655 721,261 31.16 1,436,290 28.46 0.1917
2021-02-19 2020-12-31 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 2,314,394 391,040 20.33 1,118,107 1.35 0.1643
2021-02-11 2020-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 2,314,394 391,040 1,118,107 27,651.5829
2020-11-12 2020-09-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 1,923,354 125,884 7.00 1,103,255 -1.58 0.1854
2020-11-12 2020-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,923,354 1,103,255
2020-08-11 2020-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,797,470 568,057 46.21 1,120,993 86.74 0.2163
2020-05-12 2020-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,229,413 9,526 0.78 600,311 31.06 0.1410
2020-02-11 2019-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,219,887 764,436 167.84 458,045 262.54 0.0854
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 455,451 -96,471 -17.48 126,343 -26.32 0.0252
2019-08-07 2019-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 551,922 -743,350 -57.39 171,465 -67.76 0.0335
2019-05-07 2019-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,295,272 1,036,855 401.23 531,866 451.04 0.1086
2019-02-11 2018-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 258,417 28,807 12.55 96,520 4.04 0.0223
2018-11-13 2018-09-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 229,610 78,013 51.46 92,772 77.39 0.0178
2018-11-07 2018-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 229,610 78,013 92,772
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 151,597 -11,631 -7.13 52,299 -6.96 0.0108
2018-05-10 2018-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 163,228 -52,160 -24.22 56,209 -30.59 0.0120
2018-02-13 2017-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 215,388 -129,030 -37.46 80,977 -45.96 0.0171
2017-11-09 2017-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 344,418 119,508 53.14 149,860 35.67 0.0331
2017-08-09 2017-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 224,910 -53,739 -19.29 110,463 2.30 0.0252
2017-05-10 2017-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 278,649 -58,522 -17.36 107,980 -13.03 0.0247
2017-02-06 2016-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 337,171 -697,019 -67.40 124,151 -70.19 0.0298
2016-11-04 2016-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,034,190 -401,961 -27.99 416,518 -16.95 0.1025
2016-08-08 2016-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,436,151 -27,541 -1.88 501,544 -4.93 0.1251
2016-05-10 2016-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,463,692 -1,189,931 -44.84 527,575 -63.38 0.1350
2016-02-12 2015-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 2,653,623 114,453 4.51 1,440,571 21.97 0.3617
2015-11-13 2015-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 2,539,170 103,791 4.26 1,181,069 -4.93 0.3157
2015-08-14 2015-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 2,435,379 160,171 7.04 1,242,357 20.94 0.2929
2015-05-15 2015-03-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 2,275,208 512,962 29.11 1,027,210 42.08 0.2340
2015-02-13 2014-12-31 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,762,246 218,398 14.15 722,961 29.89 0.1653
2014-12-08 2014-09-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 1,543,848 -136,585 -8.13 556,587 17.26 0.1319
2014-11-14 2014-09-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,543,848 556,587
2014-09-03 2014-06-30 13F/A-1 REGENERON PHARMACEUTICALS COMMON 75886F107 1,680,433 104,139 6.61 474,671 0.28 0.1205
2014-08-14 2014-06-30 13F REGENERON PHARMACEUTICALS COMMON 75886F107 1,680,433 474,671
2014-05-15 2014-03-31 13F REGENERON PHARMACE COMMON 75886F107 1,576,294 -274,063 -14.81 473,328 -7.06 0.1306
2014-02-26 2013-12-31 13F/A-1 REGENERON PHARMACE COMMON 75886F107 1,850,357 -707,221 -27.65 509,292 -36.35 0.1445
2014-02-13 2013-12-31 13F REGENERON PHARMACE COMMON 75886F107 1,850,357 509,292
2013-10-31 2013-09-30 13F REGENERON PHARMACE COMMON 75886F107 2,557,578 -331,959 -11.49 800,188 23.14 0.2371
2013-08-13 2013-06-30 13F REGENERON PHARMACE COMMON 75886F107 2,889,537 2,889,537 649,800 0.2071
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A REGENERON PHARMACEUTICALS OPTION Call 10,000 -52.38 7,493 -53.78 n/a n/a n/a
2026-02-11 2025-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 21,000 -1.87 16,209 34.72 n/a n/a n/a
2025-11-26 2025-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Call 21,400 -62.59 12,033 -59.93 n/a n/a n/a
2025-11-07 2025-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 21,400 12,033 n/a n/a n/a
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 57,200 147.62 30,030 104.98 n/a n/a n/a
2025-05-12 2025-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 23,100 -46.40 14,651 -52.28 n/a n/a n/a
2025-02-12 2024-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 43,100 2.38 30,701 -30.63 n/a n/a n/a
2024-12-26 2024-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Call 42,100 31.15 44,257 31.18 n/a n/a n/a
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 42,100 44,257 n/a n/a n/a
2024-12-26 2024-06-30 13F/A REGENERON PHARMACEUTICALS OPTION Call 32,100 -8.29 33,738 0.15 n/a n/a n/a
2024-08-12 2024-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 32,100 33,738 n/a n/a n/a
2024-12-26 2024-03-31 13F/A REGENERON PHARMACEUTICALS OPTION Call 35,000 -17.45 33,687 -9.54 n/a n/a n/a
2024-05-10 2024-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 35,000 33,687 n/a n/a n/a
2024-12-26 2023-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Call 42,400 28.88 37,239 37.54 n/a n/a n/a
2024-02-12 2023-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 42,400 37,239 n/a n/a n/a
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 32,900 0.61 27,075 15.23 n/a n/a n/a
2023-08-11 2023-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 32,700 -80.75 23,496 -83.17 n/a n/a n/a
2023-05-18 2023-03-31 13F/A REGENERON PHARMACEUTICALS OPTION Call 169,900 686.57 139,602 930,580.00 n/a n/a n/a
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 169,900 139,602 n/a n/a n/a
2023-02-13 2022-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 21,600 4,220.00 16 -95.64 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 500 0.00 344 16.22 n/a n/a n/a
2022-08-11 2022-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 500 0.00 296 -15.19 n/a n/a n/a
2022-05-11 2022-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 500 349 n/a n/a n/a
2021-11-12 2021-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-12 2021-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 400 223 n/a n/a n/a
2021-05-12 2021-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Call 15,500 0.00 7,488 -15.78 n/a n/a n/a
2021-02-11 2020-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 15,500 7,488 n/a n/a n/a
2020-11-12 2020-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Call 15,500 0.00 8,891 -8.03 n/a n/a n/a
2020-11-12 2020-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 15,500 8,891 n/a n/a n/a
2020-08-11 2020-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 15,500 0.00 9,667 27.74 n/a n/a n/a
2020-05-12 2020-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 15,500 -31.42 7,568 -10.82 n/a n/a n/a
2020-02-11 2019-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 22,600 -5.83 8,486 27.46 n/a n/a n/a
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 24,000 11.63 6,658 -0.31 n/a n/a n/a
2019-08-07 2019-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 21,500 61.65 6,679 22.30 n/a n/a n/a
2019-05-07 2019-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 13,300 -92.61 5,461 -91.88 n/a n/a n/a
2019-02-11 2018-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 180,000 103.62 67,230 88.23 n/a n/a n/a
2018-11-13 2018-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Call 88,400 -4.95 35,717 11.32 n/a n/a n/a
2018-11-07 2018-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 88,400 35,717 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 93,000 4.14 32,084 4.33 n/a n/a n/a
2018-05-10 2018-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 89,300 36.54 30,751 25.07 n/a n/a n/a
2018-02-13 2017-12-31 13F REGENERON PHARMACEUTICALS OPTION Call 65,400 19.34 24,588 3.12 n/a n/a n/a
2017-11-09 2017-09-30 13F REGENERON PHARMACEUTICALS OPTION Call 54,800 470.83 23,844 405.71 n/a n/a n/a
2017-08-09 2017-06-30 13F REGENERON PHARMACEUTICALS OPTION Call 9,600 -43.20 4,715 -28.00 n/a n/a n/a
2017-05-10 2017-03-31 13F REGENERON PHARMACEUTICALS OPTION Call 16,900 6,549 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 15,000 -63.41 11,239 -64.49 n/a n/a n/a
2026-02-11 2025-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 41,000 0.00 31,647 37.27 n/a n/a n/a
2025-11-26 2025-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Put 41,000 1,222.58 23,053 1,316.90 n/a n/a n/a
2025-11-07 2025-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 41,000 23,053 n/a n/a n/a
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 3,100 -75.78 1,628 -79.96 n/a n/a n/a
2025-05-12 2025-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 12,800 -65.59 8,118 -69.36 n/a n/a n/a
2025-02-12 2024-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 37,200 -48.69 26,499 -65.23 n/a n/a n/a
2024-12-26 2024-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Put 72,500 61.11 76,215 61.14 n/a n/a n/a
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 72,500 76,215 n/a n/a n/a
2024-12-26 2024-06-30 13F/A REGENERON PHARMACEUTICALS OPTION Put 45,000 -30.66 47,296 -24.28 n/a n/a n/a
2024-08-12 2024-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 45,000 47,296 n/a n/a n/a
2024-12-26 2024-03-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 64,900 -43.32 62,466 -37.89 n/a n/a n/a
2024-05-10 2024-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 64,900 62,466 n/a n/a n/a
2024-12-26 2023-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 114,500 332.08 100,564 361.13 n/a n/a n/a
2024-02-12 2023-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 114,500 100,564 n/a n/a n/a
2023-11-14 2023-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 26,500 -60.51 21,808 -54.77 n/a n/a n/a
2023-08-11 2023-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 67,100 347.33 48,214 291.19 n/a n/a n/a
2023-05-18 2023-03-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 15,000 316.67 12,325 616,150.00 n/a n/a n/a
2023-05-11 2023-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 15,000 12,325 n/a n/a n/a
2023-02-13 2022-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 3,600 16.13 3 -99.91 n/a n/a n/a
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 3,100 0.00 2,135 16.48 n/a n/a n/a
2022-08-11 2022-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 3,100 0.00 1,833 -15.33 n/a n/a n/a
2022-05-11 2022-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 3,100 2,165 n/a n/a n/a
2021-05-12 2021-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-19 2020-12-31 13F/A REGENERON PHARMACEUTICALS OPTION Put 22,500 -2.17 10,870 -17.61 n/a n/a n/a
2021-02-11 2020-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 22,500 10,870 n/a n/a n/a
2020-11-12 2020-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Put 23,000 2.22 13,193 -5.98 n/a n/a n/a
2020-11-12 2020-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 23,000 13,193 n/a n/a n/a
2020-08-11 2020-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 22,500 -38.36 14,032 -21.27 n/a n/a n/a
2020-05-12 2020-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 36,500 -49.52 17,823 -34.35 n/a n/a n/a
2020-02-11 2019-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 72,300 23.38 27,147 67.00 n/a n/a n/a
2019-11-12 2019-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 58,600 18.62 16,256 5.92 n/a n/a n/a
2019-08-07 2019-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 49,400 26.34 15,347 -4.41 n/a n/a n/a
2019-05-07 2019-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 39,100 -83.68 16,055 -82.06 n/a n/a n/a
2019-02-11 2018-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 239,600 11.96 89,491 3.50 n/a n/a n/a
2018-11-13 2018-09-30 13F/A REGENERON PHARMACEUTICALS OPTION Put 214,000 -7.36 86,465 8.50 n/a n/a n/a
2018-11-07 2018-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 214,000 86,465 n/a n/a n/a
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 231,000 33.99 79,693 34.24 n/a n/a n/a
2018-05-10 2018-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 172,400 60.37 59,368 46.89 n/a n/a n/a
2018-02-13 2017-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 107,500 14.36 40,416 -1.18 n/a n/a n/a
2017-11-09 2017-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 94,000 202.25 40,900 167.78 n/a n/a n/a
2017-08-09 2017-06-30 13F REGENERON PHARMACEUTICALS OPTION Put 31,100 6.87 15,274 35.44 n/a n/a n/a
2017-05-10 2017-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 29,100 -6.43 11,277 -26.17 n/a n/a n/a
2016-05-10 2016-03-31 13F REGENERON PHARMACEUTICALS OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F REGENERON PHARMACEUTICALS OPTION Put 30,000 0.00 16,286 16.71 n/a n/a n/a
2015-11-13 2015-09-30 13F REGENERON PHARMACEUTICALS OPTION Put 30,000 13,954 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.